NorthRock Partners LLC Decreases Stake in Humana Inc. (NYSE:HUM)

NorthRock Partners LLC reduced its stake in shares of Humana Inc. (NYSE:HUM) by 22.5% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 673 shares of the insurance provider’s stock after selling 195 shares during the quarter. NorthRock Partners LLC’s holdings in Humana were worth $213,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. Sentry Investment Management LLC acquired a new stake in Humana during the 3rd quarter worth about $179,000. Stoneridge Investment Partners LLC acquired a new position in shares of Humana in the third quarter valued at about $1,288,000. Asset Management One Co. Ltd. raised its stake in shares of Humana by 0.5% in the third quarter. Asset Management One Co. Ltd. now owns 54,428 shares of the insurance provider’s stock worth $17,240,000 after purchasing an additional 276 shares during the last quarter. National Pension Service lifted its holdings in shares of Humana by 7.4% during the third quarter. National Pension Service now owns 336,548 shares of the insurance provider’s stock worth $106,598,000 after purchasing an additional 23,100 shares during the period. Finally, Intact Investment Management Inc. boosted its position in Humana by 46.3% in the third quarter. Intact Investment Management Inc. now owns 2,780 shares of the insurance provider’s stock valued at $881,000 after buying an additional 880 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms have issued reports on HUM. Oppenheimer reduced their price target on shares of Humana from $400.00 to $280.00 and set an “outperform” rating for the company in a research report on Thursday, October 3rd. Truist Financial reduced their target price on shares of Humana from $400.00 to $260.00 and set a “hold” rating for the company in a report on Friday, October 11th. Deutsche Bank Aktiengesellschaft lowered their price target on shares of Humana from $349.00 to $250.00 and set a “hold” rating on the stock in a report on Thursday, October 3rd. Jefferies Financial Group lowered Humana from a “buy” rating to a “hold” rating and reduced their price objective for the company from $519.00 to $253.00 in a research note on Monday, October 7th. Finally, Leerink Partnrs cut Humana from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Twenty analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $315.86.

Humana Stock Up 10.8 %

NYSE HUM opened at $288.69 on Thursday. The business has a fifty day moving average price of $291.98 and a 200 day moving average price of $333.24. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The company has a market cap of $34.76 billion, a P/E ratio of 25.57, a P/E/G ratio of 1.98 and a beta of 0.52. Humana Inc. has a one year low of $213.31 and a one year high of $527.18.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. The business had revenue of $29.30 billion during the quarter, compared to analysts’ expectations of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. Research analysts anticipate that Humana Inc. will post 16.15 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a $0.885 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.23%. Humana’s dividend payout ratio (DPR) is presently 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.